Comparing ADM Tronics Unlimited (OTCMKTS:ADMT) & Atossa Genetics (NASDAQ:ATOS)

Atossa Genetics (NASDAQ:ATOS) and ADM Tronics Unlimited (OTCMKTS:ADMT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability.

Earnings & Valuation

This table compares Atossa Genetics and ADM Tronics Unlimited”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atossa Genetics	N/A	N/A	-$25.50 million	($0.24)	-2.86
ADM Tronics Unlimited	$3.20 million	2.28	-$120,000.00	N/A	N/A

ADM Tronics Unlimited has higher revenue and earnings than Atossa Genetics.

Profitability

This table compares Atossa Genetics and ADM Tronics Unlimited’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Atossa Genetics	N/A	-49.42%	-44.76%
ADM Tronics Unlimited	-3.87%	-15.66%	-5.89%

Institutional and Insider Ownership

12.7% of Atossa Genetics shares are held by institutional investors. 9.5% of Atossa Genetics shares are held by insiders. Comparatively, 73.0% of ADM Tronics Unlimited shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk & Volatility

Atossa Genetics has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500. Comparatively, ADM Tronics Unlimited has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Atossa Genetics and ADM Tronics Unlimited, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Atossa Genetics	2	0	2	1	2.40
ADM Tronics Unlimited	0	0	0	0	0.00

Atossa Genetics presently has a consensus price target of $6.33, suggesting a potential upside of 824.17%. Given Atossa Genetics’ stronger consensus rating and higher probable upside, equities research analysts clearly believe Atossa Genetics is more favorable than ADM Tronics Unlimited.

Summary

Atossa Genetics beats ADM Tronics Unlimited on 7 of the 12 factors compared between the two stocks.

About Atossa Genetics

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

About ADM Tronics Unlimited

ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.